Research Articles
Breaking the Shield: How a Tiny Nanoplatform is Revolutionizing Osteosarcoma Treatment
Discover how the MnSx dual-functional nanoplatform is transforming osteosarcoma treatment through autophagy enhancement and immune system modulation.
Beyond One-Size-Fits-All: The Quest for Universal Biomarkers in Cancer Immunotherapy
Exploring the search for reliable biomarkers to predict response to CTLA-4 and PD-1 blockade immunotherapy across different cancer types.
The Invisible Army: How HPV Infection Reshapes the Immune Landscape of Head and Neck Cancer
Explore how HPV infection creates a unique immune microenvironment in head and neck cancer, leading to better outcomes and new immunotherapy approaches.
Single-Cell Informatics: Decoding the Social Network of Cancer Cells for Better Immunotherapies
Explore how single-cell informatics is revolutionizing our understanding of the tumor microenvironment and advancing cancer immunotherapy treatments.
ZNFX1: The Cell's Hidden Weapon in the Fight Against Cancer
Discover how ZNFX1, a master regulator protein, activates cancer cell self-destruction through pathogen mimicry and mitochondrial signaling pathways.
TACC3: The Hidden Puppeteer in Lung Cancer's Immune Escape
Exploring the role of TACC3 protein in lung adenocarcinoma prognosis and immune system evasion. Discover how this biomarker influences cancer treatment and patient outcomes.
Cellular Espionage: Decoding the Silent Conversation Between Cancer and Immune Cells
Discover how HySic technology enables scientists to decode the molecular conversation between tumor cells and T cells, advancing cancer immunotherapy research.
Unlocking the Secrets of Cancer Immunity: How a Micro-Lab on a Chip is Revolutionizing Cancer Research
Discover how the Dexter microfluidic platform is transforming cancer research by enabling unprecedented observation of tumor-immune interactions in microdroplets.
The Hypoxia-Immune Signature: Decoding Cancer's Stealth Tactics to Predict Patient Survival
Discover how a novel 8-gene signature combining hypoxia and immune regulation predicts survival across six cancer types, starting with liver cancer.
Turning Cold Tumors Hot: How a Blood Cancer Drug Could Revolutionize Prostate Cancer Treatment
Discover how ibrutinib, a blood cancer drug, is being repurposed to make prostate cancer responsive to immunotherapy by targeting tumor-infiltrating B cells.